<prompt> All are Anti - VEGF EXCEPT:Pegaptanib5FUBevacizumabRanibizumab  <response>: Ans. b 5FU Ref.: A.K. Khurana 6th ed. I251-52 Anti-VEGF is a class of drug which are used for the treatment of diabetic retinopathy with neovascularization proliferative diabetic retinopathy-PDR. Available anti-VEGF are: Ranibizumab, Bevacizumab, Pegaptanib. Note: TOC for PDR- Laser photocoagulation 